1.    Committee Business

·         Call to order

·         Approval of the minutes of the October 15, 2024, meeting

2.    Patient Product Information Inserts

H.B. 203 (2025) created a process for the development and distribution of a “patient product information insert.” The Department of Health and Human Services, in consultation with the Center for Medical Cannabis Research and the cannabis processing facility that created the product, is instructed to develop patient product information inserts for medical cannabis products. Medical cannabis pharmacies are then instructed to share the patient product information insert, when available, with patients. The Working Group will hear from agency and industry leaders to better understand the different components of the patient product information insert creation and distribution process.

UCA Title 63G, Chapter 3, Utah Administrative Rulemaking Act, contains the processes for administrative rulemaking. The Utah Department of Agriculture and Food (UDAF) has authority to make rules related to their administrative duties to implement various aspects of Utah’s medical cannabis program, and has carried out this duty on a wide variety of topics ranging from medical cannabis quality assurance, medical cannabis facility licensing, and medical cannabis processing to name a few. Additionally, the Medical Cannabis Policy Advisory Board, in accordance with UCA 26B-1-435(9)(a), is instructed to review certain draft rules from UDAF. The Working Group will hear from agency leaders regarding the rulemaking process and consider whether improvements could be made.

4.    Medical Cannabis Use by Participants in Problem Solving Courts

At its December 17, 2024, meeting the Medical Cannabis Policy Advisory Board considered, and made a recommendation on, a proposal from the Utah Judicial Council, Administrative Office of the Courts, related to medical cannabis patient participation in Problem Solving Courts. The Working Group will hear from a representative of the courts on this issue.

5.    Upcoming Considerations and Priorities

The Working Group will request input from administrative agencies, industry stakeholders, interest groups, and other individuals who would like to comment on strategies to improve Utah’s medical cannabis program.